(Q38334861)

2 September 2017

Teriparatide increases the maturation of circulating osteoblast precursors (English)

1 reference

2 September 2017

0 references

5

1 reference

2 September 2017

P D'Amelio

1

1 reference

2 September 2017

C Tamone

2

1 reference

2 September 2017

F Sassi

3

1 reference

2 September 2017

L D'Amico

4

1 reference

2 September 2017

S Patanè

6

1 reference

2 September 2017

M Ravazzoli

7

1 reference

2 September 2017

L Veneziano

8

1 reference

2 September 2017

R Ferracini

9

1 reference

2 September 2017

G P Pescarmona

10

1 reference

2 September 2017

G C Isaia

11

1 reference

2 September 2017

language of work or name

English

0 references

publication date

27 May 2011

1 reference

Osteoporosis International

2 September 2017

1 reference

2 September 2017

23

1 reference

2 September 2017

4

1 reference

2 September 2017

1245-1253

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-011-1666-2

2 September 2017

0 references

cites work

Circulating osteoblast-lineage cells in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Characterization of circulating osteoblast lineage cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

The role of circulating bone cell precursors in fracture healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases in

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTP-gamma-azidoanilide photoaffinity labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Raloxifene: its ossification-promoting effect on female mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Alendronate reduces osteoclast precursors in osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Targeting the stem cell niche: squeezing blood from bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1666-2

Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells

21 January 2018

1 reference

12 December 2020

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

12 December 2020

Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women.

1 reference

12 December 2020

Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.

1 reference

12 December 2020

Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow

1 reference

12 December 2020

Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats

1 reference

12 December 2020

Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells

1 reference

12 December 2020

Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells

1 reference

12 December 2020

Parathyroid hormone represses alpha 1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice.

1 reference

12 December 2020

Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures.

1 reference

12 December 2020

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

12 December 2020

10.1007/S00198-011-1666-2

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference